MDT - Medtronic in charts: Cardiovascular portfolio sales slipped 5% Y/Y in FQ4
2024-05-23 07:05:15 ET
More on Medtronic
- Medtronic: Looking Ahead To FY 2025 EPS Growth, Shareholder Friendly Actions
- Medtronic Stock Looks Promising Before Fiscal Q4 2024 Release
- Medtronic: Dividend Aristocrat Value In Plain Sight
- Medtronic Non-GAAP EPS of $1.46 beats by $0.01, revenue of $8.59B beats by $150M
- Medtronic Q4 Earnings Preview: Cardiology, Diabetes categories to drive growth